Why did 8143.HK stock drop pre-market?

The pre-market fall reflects heavy selling and a liquidity surge: **17,031,600** shares traded versus an average of **814,764**. Weak trailing EPS **-0.03** and a negative PE contributed to risk-off sentiment ahead of any fresh company disclosures.

Is 8143.HK stock a buy after the drop?

Meyka rates 8143.HK **62.49** (Grade B, HOLD). Fundamentals are weak and valuation is high. Consider a conservative approach and wait for clearer operational news or improved volumes before buying.

What price targets and forecasts exist for 8143.HK stock?

Meyka AI's model projects **HKD 0.12** (monthly) and **HKD 0.18** (quarterly). We quote a conservative target **HKD 0.06** and an upside target **HKD 0.18** as scenario ranges; forecasts are model-based and not guarantees.

Which metrics should investors watch for 8143.HK stock updates?

Track trading volume versus average, EPS revisions, HKEX announcements on hospital contracts or asset moves, and technical resistance at **HKD 0.15** (50/200-day averages). Watch liquidity and any insider or major shareholder actions.

HK Stocks

Pre-market loser: 8143.HK Good Fellow Healthcare HKSE down 28.57% heavy volume

ByDanny Kontos March 4, 2026March 4, 2026

8143.HK stock plunged 28.57% pre-market to HKD 0.10 on 17,031,600 shares, making it one of Hong Kong’s top pre-market losers. The move follows heavy trading against a weak earnings backdrop: EPS -0.03 and a negative PE -3.33. Investors should note the liquidity spike — volume is roughly 20.90x the average — and weigh short-term volatility against the company’s small market cap in Hong Kong (HKD 112,729,998.00).